Medicare offers e-prescription incentives while DEA proposes hurdles

Why This Topic Matters

The piece helps practices understand federal e-prescribing policy developments that may affect workflow, compliance planning, and participation in Medicare incentive programs. It is especially pertinent for groups managing controlled-substance prescriptions and monitoring regulatory changes from Medicare and the DEA.

Article Sections

1. Medicare e-prescription incentive program

   Summarizes the Medicare incentive framework for electronic prescribing and the general timing of its implementation. It also notes that payment adjustments may affect practices that do not adopt a qualifying system.

2. DEA precautions would affect pain meds

   Describes proposed DEA requirements for electronic prescriptions for controlled substances and highlights the broader compliance implications for practices that prescribe medications electronically. The section also references federal comment procedures and a CMS education event.